The BDO Life Sciences M&A team acted as lead sell-side M&A adviser to the shareholder of Emotive Agency on its sale to Petauri Health, a US-based pharmaceutical services platform backed by Oak Hill Capital.

Emotive is a 75-person global medical communications agency with offices in London and Boston, US. The business supports pharma and biotech clients through the development and delivery of scientific and promotional content, disease-awareness initiatives and in-person educational programmes for healthcare professionals and patients.

The transaction strengthens Petauri Health's medical communications capabilities and expands its international reach, adding scientific, strategic and creative expertise across the drug development lifecycle.

 

"We greatly valued the support of the BDO Life Sciences & Healthcare M&A team throughout the transaction. They really understood Emotive, our market and how best to position the business. They provided clear, practical advice at every stage and took a genuinely hands-on approach, working closely with us from start to finish. Their insight, judgement and commitment were invaluable in helping us find the right strategic partner and achieve an outcome we are delighted with."

Chris Edmonds, CEO & Founder of Emotive Agency

 

The BDO project team included:

Alex Mackay
Zak Holdaway
Andrea Ryall
James Fleming
Alex Branch

The BDO Financial Modelling team included:

Janie Reid
Alexa Harley
Luke Owen